Insights into Editorial: Biologics, patents and drug prices
Insights into Editorial: Biologics, patents and drug prices Context: Pharmaceutical R&D is an expensive, time consuming and uncertain process that may take many years to complete. The useful new drugs are patented, protecting them from competition and allowing them to charge high prices. When the patent ends, other companies are allowed to supply the …
Continue reading “Insights into Editorial: Biologics, patents and drug prices”
